Brad practises complex patent litigation, including pharmaceutical proceedings under PM(NOC) Regulations. He provides strategic advice on the enforcement of patent rights and coordination and management of litigation strategies throughout multiple jurisdictions. He has sppeared as lead counsel before the Federal Court of Appeal, Federal Court, Ontario Superior Court and as worldwide coordinating litigation and IP counsel before the European Patent Office and the US International Trade Commission. A Registered Patent Agent, Brad specialises in Canadian and foreign patent and industrial design prosecution, strategic IP portfolio reviews, patentability, patent infringement and validity opinions, worldwide patent portfolio management and enforcement advice. Key clients include Teva Canada, Mylan Pharmaceuticals, Samsung Bioepis and Pharmascience Inc.
Brad was called to the Ontario Bar in 1998 and began his career at Osler in 2000, becoming a partner in 2005.
Intellectual Property Institute of Canada
American Intellectual Property Law Association
International Association for the Protection of Intellectual Property (AIPPI)
Canadian Bar Association
Frequent author in global publications including IAM and Managing Intellectual Property.
Co-author of the Canadian Intellectual Property Guide 2018 published by the Chinese National Intellectual Property Administration (CNIPA-formerly SIPO).
LL.B., M.Sc. (Chem.), B.Sc.(Chem.)
Recognized by Lexpert, Best Lawyers, IAM Patent, Managing IP and Benchmark Litigation.